Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cytokines
Biotech
Mural's IL-2 flop triggers 90% staff reduction
Mural is laying off 90% of its employees and stopping clinical development of its lead program to hunker down and seek a strategic alternative.
Nick Paul Taylor
Apr 15, 2025 9:33am
RANKL cytokine makes the thymus more youthful in mice
Dec 5, 2024 11:45am
Ipsen taps Biomunex's MAITs to treat solid tumors in $610M bet
Dec 3, 2024 6:00am
Coya shares data on IL-2 prospect in small Alzheimer's study
Oct 29, 2024 7:55am
ESMO: Innovent links cytokine to colorectal cancer responses
Sep 18, 2024 9:53am
Innovent links IL-2 fusion protein to responses in small study
Jun 14, 2024 10:00am